Elsevier

Molecular Diagnosis

Volume 5, Issue 4, December 2000, Pages 341-348
Molecular Diagnosis

Automated Mass Spectrometry: A Revolutionary Technology for Clinical Diagnostics

https://doi.org/10.1054/modi.2000.19574Get rights and content

For various diagnostic analyses and the studies of functional genomics, the use of an accurate and cost-effective analytic platform to analyze large numbers of samples is essential. An automated platform called MassArray (Sequenom, Inc, San Diego, CA), designed for high-throughput diagnostic analyses, has recently been validated. The platform combines miniaturized, two-dimensional chip arrays with proven high-fidelity enzymatic procedures and matrix-assisted laser-desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Nanoliter dispensing of samples in high-density formats of 384 or greater results in improved throughput and reduced costs. Automation prevails from the initial assay design through sample processing and data analysis, for the most part eliminating the labor component of assay development and implementation. The MassArray platform is being used in the following areas: (1) molecular diagnosis of genetic disease and infectious agents, (2) pharmacogenomics, (3) paternity and/or identity testing, and (4) agriculture (e.g., marker-assisted breeding). MALDI-TOF mass spectrometry can also be used for analyzing proteins; therefore, genotype/phenotype testing can be performed on a single platform.

References (0)

Cited by (48)

  • Clinical Mass Spectrometry in the Bioinformatics Era: A Hitchhiker's Guide

    2018, Computational and Structural Biotechnology Journal
    Citation Excerpt :

    Strategic planning of an clinical MS-based assay will not only avoid these pitfalls, but should also allow the assay to surpass the performance of traditional immunoassays due to the simultaneous discrimination and quantification of the clinically relevant sequence variations [300]. Automation of mass spectrometric analysis is still in its preliminary stage [301], and while sample preparation techniques like online solid phase extraction are available [302], the majority of clinical laboratories still employ significant amount of manual techniques in sample preparation. Henceforth round-the-clock mass spectrometry services, though reported in the literature [303], remained a rarity among clinical laboratories, at least in the authors’ experience.

  • Genetic mutation screen in early non-small-cell lung cancer (NSCLC) specimens

    2014, Clinical Lung Cancer
    Citation Excerpt :

    The extension reaction included sequence-specific hybridization and sequence-dependent termination that generated different products for the mutated and wild type alleles, each with its unique mass. Polymerase chain reaction (PCR) products were identified using mass spectrometry.16,17 Multiplexed PCR was performed 384-well plates, 5-μL volumes containing 0.1 units of Taq polymerase (Hotstar Taq, Quiagen), 50 ng of genomic DNA, 200 nmol of each PCR primer, and 0.2 mmol of deoxynucleotide (dNTP).

  • Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort

    2009, Human Immunology
    Citation Excerpt :

    Two genotyping platforms were used to assay the different variants. The p.Lys216Glu SNP in the BPI gene (rs4358188) was genotyped with both the ABI TaqMan MGB diallelic discrimination system and the Sequenom MassArray system [44]. The promoter variants in the CD14 gene (c.-159 T>C, rs7524551) and the TLR9 gene (c.-1237 C>T, rs5743836) were genotyped with the ABI TaqMan MGB diallelic discrimination system.

  • Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population

    2008, Digestive and Liver Disease
    Citation Excerpt :

    The four genotyped SNPs and their build 35 coordinates are SNP A (rs7017866; 6889 kb), SNP B (rs12682030; 6891 kb), SNP C (rs10095331; 6901 kb), and SNP D (rs4610776; 6902 kb). Genotyping was performed using the Sequenom® MassArray platform [24]. Primers, sequences and conditions are available on request.

View all citing articles on Scopus
View full text